NEW ORLEANS, July 21, 2017 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 11, 2017 to file lead plaintiff applications in a securities class action lawsuit against HD Supply Holdings, Inc. (Nasdaq:HDS), if they purchased the Company’s securities between November 9, 2016 and June 5, 2017, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of Georgia.
Get Help
HD Supply Holdings investors should visit us at https://www.claimsfiler.com/cases/nasdaq-hds or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
HD Supply Holdings and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
The alleged false and misleading statements and omissions include, but are not limited to, that: (i) HD Supply’s 2017 operating and growth leverage guidance was not feasible (ii) the recovery of its Facilities Maintenance supply chain was not in line with prior expectations and planning; (iii) the sale of its Waterworks segment was being explored; (iv) Defendant Joseph DeAngelo, with full knowledge of these undisclosed materially-adverse facts, sold off his personal holdings of HD Supply stock, resulting in over $54 million in profits; and (v) as a result of the foregoing, HD Supply’s financial statements were materially false and misleading at all relevant times.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Italy Fines Apple €98.6 Million Over App Store Dominance
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares 



